David Brusegard

This profile gathers the share dealings of David Brusegard in Generex Biotechnology Corp. Over a trading history stretching from 9 February 2016 to 16 February 2016, the count stands at 2 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 16 February 2016, the filings show an option exercise in Generex Biotechnology Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.